Strong Norwegian oncology presence at DNB Nordic Healthcare Conference 2022.
The DNB Nordic Healthcare Conference was back with in-person attendance last week, connecting some of the best Nordic health companies with eager investors at the DNB main office in Oslo.
“Health is key in Norway’s transition to a green economy. DNB shows great social responsibility by bringing together key players in business, investment, and health. It is encouraging to see the high-quality of the companies at this conference,” commented Ketil Widerberg, general manager at Oslo Cancer Cluster.
The conference included four different sessions with company presentations. A total of 14 members from Oslo Cancer Cluster were there, demonstrating the first-class cancer innovation emerging from Norwegian research environments.
Up-and-coming companies competed
Eleven health start-ups competed for the Health Prize of NOK 1 million during the Venture Session. Six members of Oslo Cancer Cluster were selected for this competition, and two were fast-tracked for the final. Here are snapshots from their pitches:
The companies ArxxTherapeutics, Bulbitech, Clexbio, Helseboka and Nadenod also pitched in this session. After a nerve-racking final, with heated discussions in the investor panel and a packed auditorium voting for their favorite start-up, Clexbio won the prestigious prize.
Oncology companies drew a crowd
There were two sessions with listed companies and one session with private companies, including 9 members from Oslo Cancer Cluster in total. The rooms filled up quickly, and the companies received many questions from curious investors. Here are some messages from their presentations.
Dan Schneider, CEO of Photocure, described how the company is improving the lives of bladder cancer patients with unique photodynamic technology for diagnosis and treatment. Visit the Photocure website to learn more.
Jan Alfheim, CEO of Oncoinvent, presented how the company uses alpha-emitting radiotherapeutics to kill all cancer cells in body cavities, including micro-metastatic disease. Visit the Oncoinvent website to learn more.
Visit the BerGenBio website to learn more.
Visit the Zelluna Immunotherapy website to learn more.
Visit the Exact Therapeutics website to learn more.
Visit the Nykode Therapeutics website to learn more.
Visit the Ultimovacs website to learn more.
Visit the Targovax website to learn more.
The conference was organised by DNB with support from Oslo Cancer Cluster and Norway Health Tech. The event also collaborates with the following Norwegian clusters and networks in healthcare: The Life Science Cluster, Norwegian Smart Care Cluster, The Life Science Cluster, Norwegian Inflammation Network, Nansen Neuroscience Network and Aleap.